One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer
VanessaDi LallaaMichael J.KucharczykbAlexander W.WyattcdFelix Y.FengeStephanProbstfGwenaelleGravisgJonathanSohFredSaadiTamimNiazia
There is a Need for a Universal Language in the Reporting and Grading of Complication and Intervention Events to Ensure Comparability and Improvement of Surgical Care
ChristopherSolimanab†Niranjan J.Sathianathenab†GianlucaGiannarinicPatrick Y.WuethrichdHenry Y.C.PanaBenjamin C.ThomasabePhilipDundeeabeMarcus G.CumberbatchfRajeshNairgNathanLawrentschukabMarc A.Furrerabeh
Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy
QingChengabWilliamButlercYingluZhoucHongZhangcLuTangcKathrynPerkinsoncXufengChencXiaoyin “Sara�JiangbcShannon J.McCallbcBrant A.InmanabJiaotiHuangbc
The Needle in the Haystack: The Presence of Castrate-resistant Prostate Cancer Cells in Hormone-naïve Prostate Cancer
AminAliabEstherBaenaac
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry
Burcu F.DarstabRaymondHughleyaAaronPfennigcUjaniHazracCaoqiFanadPeggyWanaXinShengaLucyXiaaCarolineAndrewseFeiChenaSonja I.BerndtfZsofiaKote-JaraigKoveelaGovindasamighJeannette T.BensenijSue A.InglesabBenjamin A.RybickikBarbaraNemesurelEsther M.Johnm…Christopher A.Haimanab
Race, Biology, Disparities, and Prostate Cancer
Andrew J.VickersaAymenElfikybVincent L.FreemancMackRoach3rdd
Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy
MatthewMossanena†Filipe L.F.Carvalhoa†VinayakMuralidharbf†Mark A.PrestonaBrendanReardoncJake R.ConwaycCatherineCurrancDoryFreemancSybilShadGuruSonpavdecMichelleHirscheAdam S.KibelaEliezer M.Van AllencKent W.Mouwb
Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy: A Rare Entity with Unique Genomic Features
AveryBraunaPhillip H.Abboshab
Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review
EduardRousselaUmbertoCapitaniobcAlexanderKutikovdEgbertOosterwijkeIvanPedrosafghSteven P.RoweijMichael A.Gorinkl
Too Hot to Handle, Too Cold to Care: The Future of Renal Mass Imaging
MeganPruntyabDianaMageecLauraBukavinaabc
What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
LongbinXiongabc†Jane K.Nguyend†YuluPengabc†ZhaohuiZhouabc†KangNingabcNanJiaeJingNieeDongxiangWenbcZeshenWuabcGustavoRoversifDiego AguilarPalaciosfEmilyAbramczykfCarlosMunoz-LopezfJack A.CampbellfYunCaobcgWencaiLihXuepeiZhanghZhisongHei…ZhilingZhangabc
Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?
Kevin B.GinsburgJared P.SchoberAlexanderKutikov
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium
KatharinaBeyera†LisaMorisb†MichaelLardascMuhammad ImranOmardJemmaHealeydSheelaTripatheedGiorgioGandagliaeLionne D.F.VenderbosfEleniVradigThomasvan den BroeckbPeter-PaulWillemsehTiagoAntunes-LopesijLuisPacheco-FigueiredoijSerenellaMonagaskFrancescoEspertolStephenFlahertymZsuzsannaDevecserinThomas B.L.Lamd…MiekeVan Hemelrijcka‡
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial
BradleyMcGregoraPeter H.O'DonnellbArjunBalarcDanielPetrylakdJonathanRosenbergeEvan Y.YufDavid I.QuinngElisabeth I.HeathhMaryCampbelliZsoltHeppiCarolineMcKayjJoyceSteinbergjAntoineRegnaultkFloraMazerollekMatthew D.Galskyl
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
GottfridSjödahlabJohanAbrahamssonabKarinHolmstencdCarinaBernardoeGunillaChebilePontusErikssoneIvaJohanssonePetterKollbergabClaesLindhcKristinaLövgreneNour-al-DainMarzoukaeHansOlssonfMattiasHöglundeAndersUlléncgFredrikLiedbergab
Robotic-assisted Lingual Mucosal Graft Ureteroplasty for the Repair of Complex Ureteral Strictures: Technique Description and the Medium-term Outcome
KunlinYangabc†ShuboFanabc†JieWangabc†LuYinabcZhihuaLiabcShengweiXiongabcGuanpengHanabcChangMengabcPengZhangdXuesongLiabcLiqunZhouabc
Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer
MarkoBabjuk
Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicenter, Phase 2 Study
Cyrill A.RentschaStefanieHayozbRichard L.Cathomasc
Re: How to Manage Patients with Suspected Upper Tract Urothelial Carcinoma in the Pandemic of COVID-19?
PetrisorGeavleteRazvanMultescuBogdanGeavlete
Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial
MutieRaslanaClaudiaMercaderaAlastair D.Lamba
Re: Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: Results from the FLAME Randomized Phase III Trial
JochenWalz*
Re: Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
KarimBensalahaZine-EddineKheneaChristopheMassardbc
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup
GiancarloMarraabArmandoStabilecPaoloGonteroaFrancescoMontorsicAlbertoBriganticGiorgioGandagliacYoung Academic Urologists Prostate Cancer Working Party
Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia’s Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup
Valentin H.MeissnerJürgen E.GschwendMatthias M.Heck
Re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.012
Shun-FaHungShyi-ChunYiiShiu-DongChung
Reply to Shun-Fa Hung, Shyi-Chun Yii, and Shiu-Dong Chung’s Letter to the Editor re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.012
PengHeXiaozhouZhouZhiwenChen
Re: Oscar Reig Torras, Akhilesh Mishra, Alana Christie, et al. Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.003
ZhanWangYangZhaoYushiZhang
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019
YeLeiaSujunHanaNianzengXingab
Re: Jana S. Hopstaken, Joyce G.R. Bomers, Michiel J.P. Sedelaar, et al. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol 2022;81:5–33
FrancescoMontorsiArmandoStabileGiorgioGandagliaAlbertoBriganti
Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–293
ChenDongaSung-LangChenabWen-WeiSungabc
Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93.
KarinWelenaEbbaRosendalbEvaFreyhultcAnne-MarieFors ConnollybdAnna K.ÖverbybdAndreasJosefssonaef
